Moderna (MRNA) EBT Margin Growth (1y) (2018 - 2026)

Moderna (MRNA) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Moderna 22.52 Bn 17.32 Bn -566.00 Mn 54,966.00

Historic Data

Download Data
DateValue
Mar 31, 2026 54,966.00
Dec 31, 2025 472.00
Sep 30, 2025 -1,953.00
Jun 30, 2025 -4,535.00
Mar 31, 2025 -19,499.00
Dec 31, 2024 -12,506.00
Sep 30, 2024 10,806.00
Jun 30, 2024 -2,228.00
Mar 31, 2024 -68,122.00
Dec 31, 2023 -3,006.00
Sep 30, 2023 -14,311.00
Jun 30, 2023 -56,053.00
Mar 31, 2023 -8,610.00
Dec 31, 2022 -4,247.00
Sep 30, 2022 -3,531.00
Jun 30, 2022 -1,825.00
Mar 31, 2022 467.00
Dec 31, 2021 12,248.00
Sep 30, 2021 21,925.00
Jun 30, 2021 24,498.00